1210 related articles for article (PubMed ID: 29191699)
1. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
3. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
4. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
[TBL] [Abstract][Full Text] [Related]
5. Benzimidazole Derivatives as New and Selective Inhibitors of Arginase from
Betancourt-Conde I; Avitia-Domínguez C; Hernández-Campos A; Castillo R; Yépez-Mulia L; Oria-Hernández J; Méndez ST; Sierra-Campos E; Valdez-Solana M; Martínez-Caballero S; Hermoso JA; Romo-Mancillas A; Téllez-Valencia A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948408
[TBL] [Abstract][Full Text] [Related]
6. Antileismanial activity, mechanism of action study and molecular docking of 1,4-bis(substituted benzalhydrazino)phthalazines.
Romero AH; Rodríguez N; Oviedo H; Lopez SE
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800299. PubMed ID: 31012160
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
8. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis.
Stroppa PHF; Antinarelli LMR; Carmo AML; Gameiro J; Coimbra ES; da Silva AD
Bioorg Med Chem; 2017 Jun; 25(12):3034-3045. PubMed ID: 28433512
[TBL] [Abstract][Full Text] [Related]
10. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
11. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
13. Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.
Dikhit MR; Purkait B; Singh R; Sahoo BR; Kumar A; Kar RK; Ansari MY; Saini S; Abhishek K; Sahoo GC; Das S; Das P
Drug Des Devel Ther; 2016; 10():1753-61. PubMed ID: 27307706
[TBL] [Abstract][Full Text] [Related]
14. SQ109 inhibits proliferation of Leishmania donovani by disruption of intracellular Ca
Gil Z; Martinez-Sotillo N; Pinto-Martinez A; Mejias F; Martinez JC; Galindo I; Oldfield E; Benaim G
Parasitol Res; 2020 Feb; 119(2):649-657. PubMed ID: 31897791
[TBL] [Abstract][Full Text] [Related]
15. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Effect of
Nieto-Meneses R; Castillo R; Hernández-Campos A; Nogueda-Torres B; López-Villegas EO; Moreno-Rodríguez A; Matadamas-Martínez F; Yépez-Mulia L
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203832
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
Freitas CS; Santiago SS; Lage DP; Antinarelli LMR; Oliveira FM; Vale DL; Martins VT; Magalhaes LND; Bandeira RS; Ramos FF; Pereira IAG; de Jesus MM; Ludolf F; Tavares GSV; Costa AV; Ferreira RS; Coimbra ES; Teixeira RR; Coelho EAF
Exp Parasitol; 2023 Aug; 251():108555. PubMed ID: 37247802
[TBL] [Abstract][Full Text] [Related]
18. In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.
de Morais-Teixeira E; Gallupo MK; Rodrigues LF; Romanha AJ; Rabello A
J Antimicrob Chemother; 2014 Jan; 69(1):150-4. PubMed ID: 23970484
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.
Zhu X; Farahat AA; Mattamana M; Joice A; Pandharkar T; Holt E; Banerjee M; Gragg JL; Hu L; Kumar A; Yang S; Wang MZ; Boykin DW; Werbovetz KA
Bioorg Med Chem Lett; 2016 May; 26(10):2551-2556. PubMed ID: 27048943
[TBL] [Abstract][Full Text] [Related]
20. In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.
Valdivieso E; Mejías F; Torrealba C; Benaim G; Kouznetsov VV; Sojo F; Rojas-Ruiz FA; Arvelo F; Dagger F
Acta Trop; 2018 Jul; 183():36-42. PubMed ID: 29604246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
